Hong-min M. Liu - Publications

A comprehensive review of the mechanism and application prospect of PARP dual-target inhibitors in tumor treatment.

Journal: European journal of medicinal chemistry

Published: June 16, 2026

Biguanide‑modified ursolic acid as a multifunctional lipid‑mimetic carrier of DOX liposome for synergistic chemotherapy.

Journal: Drug delivery and translational research

Published: April 21, 2026

Cholesterol-butyl-biguanide conjugate as a novel excipient enhances the efficacy of doxorubicin liposomes against triple-negative breast cancer by potentiating immunogenic cell death.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: October 12, 2025

Synthesis and identification of a novel selective USP7 degrader that inhibits the migration of upper gastrointestinal cancer cells without affecting proliferation.

Journal: European journal of medicinal chemistry

Published: September 09, 2025

Design, synthesis and biological evaluation of novel histone deacetylase 6 inhibitors containing indole-based cap groups.

Journal: Bioorganic & medicinal chemistry letters

Published: July 16, 2025

The prospects and challenges of small molecule drugs in the treatment of Duchenne muscular dystrophy.

Journal: European journal of medicinal chemistry

Published: June 09, 2025

The LSD1/HDAC dual-target inhibitor for cancer therapy: Challenge and opportunity.

Journal: Bioorganic chemistry

Published: June 05, 2025

Discovery of W478, a novel SHMT2 inhibitor for the treatment of esophageal carcinoma.

Journal: Bioorganic chemistry

Published: May 05, 2025

Molecular hybridization strategy - discovery of 2,3-diarylpyrazine derivatives as potent Skp2 inhibitors with improved anti-tumor activity and enhanced cisplatin sensitivity.

Journal: European journal of medicinal chemistry

Published: March 12, 2025

A review-plant medicine and its extraction components inhibit influenza virus.

Journal: Bioorganic & medicinal chemistry letters

Published: January 22, 2025

A comprehensive review of new small molecule drugs approved by the FDA in 2022: Advance and prospect.

Journal: European journal of medicinal chemistry

Published: July 16, 2024

The recent advance of PROTACs targeting BCR-ABL for the treatment of chronic myeloid leukemia.

Journal: Bioorganic chemistry

Published: June 06, 2024